Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)
Public ClinicalTrials.gov record NCT00914186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy, Safety and Tolerability of TS-022 in Adult Patients With a Diagnosis of Atopic Dermatitis (AD) With Moderate to Very Severe Pruritus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose and (primary) objectives of this study are to evaluate the efficacy, safety, and tolerability of TS-022 in adults with atopic dermatitis who have moderate to very severe pruritus (itching), following a 28-day regimen of twice-daily topical application.
Study identification
- NCT ID
- NCT00914186
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2009 (Type not available)
- Primary completion
- May 2010 (Actual)
- Completion
- Oct 2010 (Actual)
- Last update posted
- Dec 1, 2011
2009 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD | La Jolla | California | 92037 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Ameriderm Research | Jacksonville | Florida | 32216 | — |
| Ameriderm Research | Kissimmee | Florida | 34741 | — |
| FXM Research | Miramar | Florida | 33027 | — |
| Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| Gwinnett Clinical Research | Snellville | Georgia | 30078 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Haber Dermatology and Cosmetic Surgery, Inc | South Euclid | Ohio | 44118 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| J & S Studies | College Station | Texas | 77845 | — |
| Center for Clinical Studies | Houston | Texas | 77030 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00914186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2011 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00914186 live on ClinicalTrials.gov.